188 related articles for article (PubMed ID: 28110689)
1. Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation.
Norooznezhad AH; Norooznezhad F
Med Hypotheses; 2017 Feb; 99():15-18. PubMed ID: 28110689
[TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
[TBL] [Abstract][Full Text] [Related]
3. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
Zhang H; Issekutz AC
Am J Pathol; 2002 Jun; 160(6):2219-30. PubMed ID: 12057924
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis--a possible target for novel therapies?
Canavese M; Altruda F; Ruzicka T; Schauber J
J Dermatol Sci; 2010 Jun; 58(3):171-6. PubMed ID: 20430590
[TBL] [Abstract][Full Text] [Related]
5. Curcumin: hopeful treatment of hemophilic arthropathy via inhibition of inflammation and angiogenesis.
Norooznezhad F; Rodriguez-Merchan EC; Asadi S; Norooznezhad AH
Expert Rev Hematol; 2020 Jan; 13(1):5-11. PubMed ID: 31657968
[No Abstract] [Full Text] [Related]
6. Tranilast could has potential therapeutic value in the treatment of psoriasis.
Mansouri K; Motlagh HR; Keshavarz M
Med Hypotheses; 2011 Feb; 76(2):217-9. PubMed ID: 21030156
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
8. Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation.
Wen J; Pei H; Wang X; Xie C; Li S; Huang L; Qiu N; Wang W; Cheng X; Chen L
J Dermatol Sci; 2014 Jun; 74(3):242-50. PubMed ID: 24685902
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells.
Ramer R; Fischer S; Haustein M; Manda K; Hinz B
Biochem Pharmacol; 2014 Sep; 91(2):202-16. PubMed ID: 24976505
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.
Corsini M; Moroni E; Ravelli C; Andrés G; Grillo E; Ali IH; Brazil DP; Presta M; Mitola S
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):136-45. PubMed ID: 24233491
[TBL] [Abstract][Full Text] [Related]
12. The Role of Hypoxia in Angiogenesis and Extracellular Matrix Regulation of Intervertebral Disc Cells During Inflammatory Reactions.
Kwon WK; Moon HJ; Kwon TH; Park YK; Kim JH
Neurosurgery; 2017 Nov; 81(5):867-875. PubMed ID: 28475716
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
[TBL] [Abstract][Full Text] [Related]
15. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.
Lee JD; Huh JE; Jeon G; Yang HR; Woo HS; Choi DY; Park DS
Int Immunopharmacol; 2009 Mar; 9(3):268-76. PubMed ID: 19111632
[TBL] [Abstract][Full Text] [Related]
16. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis drives psoriasis pathogenesis.
Heidenreich R; Röcken M; Ghoreschi K
Int J Exp Pathol; 2009 Jun; 90(3):232-48. PubMed ID: 19563608
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis.
Liu Y; Yang G; Zhang J; Xing K; Dai L; Cheng L; Liu J; Deng J; Shi G; Li C; Su X; Zhang S; Yang Y; Li J; Yu D; Xiang R; Wei Y; Deng H
Int Immunopharmacol; 2015 Sep; 28(1):731-43. PubMed ID: 26263167
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model.
Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ
Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338
[TBL] [Abstract][Full Text] [Related]
20. The role of angiogenesis in the pathogenesis of psoriasis.
Chua RA; Arbiser JL
Autoimmunity; 2009 Nov; 42(7):574-9. PubMed ID: 19863376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]